Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism
2024-05-03
Long Beach, Calif. – May 3, 2024 – Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results were presented today as late-breaking science at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions and simultaneously published in JSCAI.
PE is a serious cardiovascular event where a blood clot causes issues with blood flow and oxygen levels in the lungs. It can be ...
Biomimetic transcatheter aortic heart valve offers new option for aortic stenosis patients
2024-05-03
Long Beach, Calif. – May 3, 2024 – Recent findings from a study on a transcatheter heart valve (THV) system, which includes a new class of transcatheter aortic valve, showed positive results in the device's ability to function as a healthy and natural aortic valve in patients with aortic stenosis (AS). The late-breaking data will be presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
AS is a thickening and narrowing of the aortic valve that can reduce blood flow to ...
SMART trial reaffirms hemodynamic superiority of TAVR self-expanding valve in aortic stenosis patients with a small annulus over time and regardless of age
2024-05-03
Long Beach, Calif. – May 3, 2024 – Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) and confirmed valve performance superiority over time based on hemodynamics. Data also showed similar positive results in two age groups (< or ≥ 80 years old). The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions ...
Metastatic prostate cancer research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition
2024-05-03
Study Title: Efficacy of [177Lu]Lu-PSMA-617 versus ARPI change in taxane-naive patients with metastatic castration-resistant prostate cancer by pre-randomization ARPI (PSMAfore)
Publication: American Urological Association Annual Meeting Plenary, May 3, 2024
Dana-Farber Cancer Institute author: Xiao X. Wei, MD
Summary: In a follow-on analysis of results from the phase 3 PSMAfore study, clinical investigators from Dana-Farber and elsewhere found that clinical outcomes consistently favored 177Lu-PSMA-617 over a change from one androgen receptor pathway inhibitor (ARPI) to another, regardless of which ARPI patients received first. ...
Studies highlight need for tailored treatment options for women with peripheral artery disease
2024-05-03
Late-Breaking Data Shows Endovascular Therapy Results in One-Third Reduction in Post-Procedural Complications for Women with PAD
Women and Asian Americans Less Likely to Undergo Endovascular Revascularization for PAD Compared to Men and Other Races
Long Beach, Calif. – May 3, 2024 – New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral artery disease (PAD), including endovascular therapy and revascularization. The data ...
Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism
2024-05-03
Long Beach, Calif. – May 3, 2024 – New data from the REAL-PE analysis investigated catheter-based pulmonary embolism (PE) treatment, showing women and Black people were less frequently treated with minimally invasive therapy compared to men or non-Black patients. The late-breaking results were presented today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.
...
Pilot program improves well-being of families during advanced care planning
2024-05-03
WASHINGTON (May 3, 2024) – Children with life-limiting rare diseases and their caregivers face tremendous stress and anxiety about the heart-breaking decisions before them. A new intervention – designed at Children’s National Hospital to support the palliative needs of these families – improved their spiritual and emotional well-being, according to new research published in the journal, Pediatrics.
Called FACE Rare (FAmily CEntered Pediatric Advance Care Planning Intervention for Rare Diseases), the counseling tools were found to be safe, effective and increased feelings of peace among families in this underserved ...
The key role of Galectin-3 in brain tumour development
2024-05-03
A research group at the Department of Biochemistry and Molecular Biology of the University of Seville has made a significant advance by discovering the crucial role of the protein Galectin-3 in the progression of various types of brain tumours. In these tumours, the most abundant immune system cells, microglia and macrophages, overexpress Galectin-3, which creates an immunosuppressed environment which inhibits the action of other immune cells against cancer cells.
In vitro findings have shown that specific inhibition of Galectin-3 in microglial cells promotes expression of proinflammatory markers and reverses the presence of key immunosuppressive ...
Announcing Junevity as Tier 3 Sponsor of ARDD 2024
2024-05-03
The University of Copenhagen is excited to announce Junevity as a Tier 3 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.
Junevity is rewinding diseases of aging with novel transcription factor medicines. Based on 6 years of breakthrough research at UCSF, Junevity's REWINDTM platform identifies new targets based on large-scale genomics, machine learning, and cell aging experiments. Junevity is advancing multiple therapeutic programs towards ...
Climate change amplifies severity of combined wind-rain extremes over the UK and Ireland
2024-05-03
Climate change will cause an increase in extreme winter storms combining strong winds and heavy rainfall over the UK and Ireland, new research has shown.
The new study was led by experts at Newcastle University and the Met Office and investigated how future climate change may influence compound wind-rain extremes, which are events where extreme wind and rainfall occur simultaneously.
The researchers analysed data from climate simulations covering control (1981-2000) and future (2060-2081) periods, ...
Exeter announces new £3.4 million global funding for solutions to antifungal drug resistance
2024-05-03
Researchers working on solutions for antifungal resistance are being encouraged to apply to a new £3.4 million fund led by the University of Exeter with UK government funding.
The new fund, called FAILSAFE (Fungal AMR Innovations for LMICS: Solutions and Access For Everyone), is being launched by the University of Exeter’s MRC Centre for Medical Mycology, in partnership with the UK Department of Health and Social Care’s Global AMR Innovation Fund (GAMRIF).
Life-threatening fungal diseases take as many lives annually as TB or malaria, but the organisms ...
In medieval England, leprosy spread between red squirrels and people, genome evidence shows
2024-05-03
Evidence from archaeological sites in the medieval English city of Winchester shows that English red squirrels once served as an important host for Mycobacterium leprae strains that caused leprosy in people, researchers report May 3 in the journal Current Biology.
“With our genetic analysis we were able to identify red squirrels as the first ancient animal host of leprosy,” says senior author Verena Schuenemann of the University of Basel in Switzerland. “The medieval red squirrel strain we recovered is more closely related to medieval human strains from the same city than to strains isolated from infected ...
Source of pregnancy complications from infections revealed by placenta map
2024-05-03
The first panoramic view of infection pathways in the human placenta has been created, which could highlight potential drug targets to develop pregnancy-safe therapies for malaria, toxoplasmosis and listeria, all diseases that can cause severe pregnancy complications.
Researchers from the Wellcome Sanger Institute, the University of Cambridge, the University of Dundee, and collaborators, used novel ‘mini placenta’ models to map the placental response to infections in early development. This ...
Lepra in the middle ages: New insights on transmission pathways through squirrels
2024-05-03
Researchers at the University of Basel and the University of Zurich have been able to prove that British squirrels carried leprosy bacteria as early as the Middle Ages. Further results revealed a link between the pathogens found in the medieval rodents and those in the local human population during that period.
Skin spots, deformed noses, ulcers: leprosy, is an infectious disease that can bring about some serious symptoms. The bacterium responsible, Mycobacterium leprae, which still infects around 200,000 people each year especially in the Global South, also has a long history in Europe. The international research group led by paleogeneticist Professor Verena Schünemann ...
The Foundational Questions Institute, FQxI, appoints Pinar Emirdag to Board of Directors
2024-05-03
The Foundational Questions Institute, FQxI, a philanthropically-funded science funding agency and think tank, is delighted to announce that Dr Pinar Emirdag has been appointed to the Institute’s Board of Directors.
Emirdag, a financial services executive and entrepreneur, is currently director of Hupomone Ventures, having previously spearheaded industry-changing initiatives at institutions such as JP Morgan, Citi and the London Stock Exchange and at start-ups including Lava Trading and Clearmatics. FQxI’s Chief Operating Officer Kavita ...
Stretchable e-skin could give robots human-level touch sensitivity
2024-05-03
A first-ever stretchy electronic skin could equip robots and other devices with the same softness and touch sensitivity as human skin, opening up new possibilities to perform tasks that require a great deal of precision and control of force.
The new stretchable e-skin, developed by researchers at The University of Texas at Austin, solves a major bottleneck in the emerging technology. Existing e-skin technology loses sensing accuracy as the material stretches, but that is not the case with this new version.
"Much like human skin has to stretch and bend ...
Researchers collaborate with the shipping industry to cut costs, fuel consumption and greenhouse gas emissions in shipping
2024-05-03
A common challenge in shipping occurs when ships arrive promptly at their destination, only to find a crowded harbour. Subsequently, they are often required to wait outside the harbour or anchor until port services and a quayside become available.
According to a report from the International Maritime Organization (IMO), it is not uncommon for ships to spend between 5-10% of their time waiting to enter port. Excessive speeds followed by extended waiting times with engines running result in a notable increase in fuel consumption. This is a problem that impacts both the climate and the economy.
Several European universities, ports, shipping companies and technology firms have now joined forces ...
Towards transparent and antimicrobial surfaces for touch displays
2024-05-03
The interest in antimicrobial solutions for personal and multi-user touch screens, such as tablets and mobile devices, has grown in recent years. Traditional methods like sprayable alcohols or wipes are not ideal for these delicate displays. Antimicrobial coatings applied directly to the glass are a promising alternative, but only if they are transparent and long-lasting. Previous proposed coating solutions, such as photocatalytic metal oxides (e.g., TiO2 and ZnO), have posed some challenges. Additionally, these coatings typically require light and moisture to be antimicrobial and eliminate the microbes present on the surface.
Copper ...
Number of male Oxbridge students from elite schools declined significantly in the middle of the twentieth century, study shows
2024-05-03
The number of male students at the University of Oxford from elite schools declined significantly by the middle of the twentieth century, a new study shows.
In contrast the proportion of female students remained steady. Those with fathers with professional jobs rose dramatically by the 1960s, according to the analysis.
At the beginning of the century around 25 to 35 per cent had fathers in professional occupations. This had risen to around 50 per cent among those arriving at Oxford in the 1960s.
The research, published in the journal Gender & History, was ...
A cost-efficient path to a renewable energy grid for Australia
2024-05-03
A model charts the most cost-efficient path to a fully renewable electricity grid for Australia. Raheel Ahmed Shaikh and colleagues modeled possible scenarios for Australia’s eastern and western grids, using solar and wind generation, short-to-long-term energy storage, and financial input data to explore low-cost capacity mix. Going completely renewable would require significant expansion of both generation and storage. Interconnecting the two grids would reduce generation capacity needs by 6% and storage power capacity needs by 14%. The least cost renewable-only grid would be dominated by wind, ...
Leadership in MS Rehabilitation recognized: John DeLuca, PhD, awarded 2024 Giants of MS® Honor
2024-05-03
East Hanover, NJ – May 3, 2024 – John DeLuca, PhD, of Kessler Foundation was named recipient of the 2024 Giants of Multiple Sclerosis® award for rehabilitation. He was one of seven inductees announced by NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) this week. Dr. DeLuca is senior vice president, Research and Training at the Foundation and a professor in the departments of Physical Medicine & Rehabilitation and Neurology at Rutgers New Jersey Medical School.
Established in 2021, the Giants of Multiple Sclerosis award honors trailblazers, innovators, and visionaries ...
High rates of hip osteoarthritis among older adults with spinal deformity
2024-05-03
Waltham — April 30, 2024 — One-third of patients undergoing surgery for adult spinal deformity (ASD) also have severe osteoarthritis (OA) of the hip – which is associated with worse spinal alignment and physical functioning, reports a study in The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
These differences persist even following operative treatment of ASD, ...
ChatGPT can be helpful for Black women’s self-education about HIV, PrEP
2024-05-03
Waltham — May 3, 2024 — The artificial intelligence (AI) chatbot called ChatGPT is a powerful way for Black women to educate themselves about HIV prevention, as it provides reliable and culturally sensitive information, according to a study in The Journal of the Association of Nurses in AIDS Care (JANAC), the official journal of the Association of Nurses in AIDS Care. JANAC is published in the Lippincott portfolio by Wolters Kluwer.
"In addition to immediately available information, regardless of time or geographic location, privacy ...
Research quantifies “gap” in carbon removal for first time
2024-05-03
New research involving the University of East Anglia (UEA) suggests that countries’ current plans to remove CO2 from the atmosphere will not be enough to comply with the 1.5 ºC warming limit set out under the Paris Agreement.
Since 2010, the United Nations environmental organisation UNEP has taken an annual measurement of the emissions gap - the difference between countries’ climate protection pledges and what is necessary to limit global heating to 1.5 ºC, or at least below 2 ºC.
The ...
Study: ChatGPT displays lower concern for child development “warning signs” than physicians
2024-05-03
Artificial intelligence (AI) tool ChatGPT displayed lower concern than physicians in 36% of potential developmental delays, according to a new study. The research will be presented at the Pediatric Academic Societies (PAS) 2024 Meeting, held May 3-6 in Toronto.
Researchers found ChatGPT made different conclusions about the abnormality of a potential delay than pediatricians 41% of the time.
The study investigated how ChatGPT responded to parents’ concerns whether their child’s development was normal or abnormal, including ...
[1] ... [1034]
[1035]
[1036]
[1037]
[1038]
[1039]
[1040]
[1041]
1042
[1043]
[1044]
[1045]
[1046]
[1047]
[1048]
[1049]
[1050]
... [8661]
Press-News.org - Free Press Release Distribution service.













